日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma

MNK1/2抑制可限制KIT突变型黑色素瘤的致癌性和转移性

Zhan, Yao; Guo, Jun; Yang, William; Goncalves, Christophe; Rzymski, Tomasz; Dreas, Agnieszka; Żyłkiewicz, Eliza; Mikulski, Maciej; Brzózka, Krzysztof; Golas, Aniela; Kong, Yan; Ma, Meng; Huang, Fan; Huor, Bonnie; Guo, Qianyu; da Silva, Sabrina Daniela; Torres, Jose; Cai, Yutian; Topisirovic, Ivan; Su, Jie; Bijian, Krikor; Alaoui-Jamali, Moulay A; Huang, Sidong; Journe, Fabrice; Ghanem, Ghanem E; Miller, Wilson H Jr; Del Rincón, Sonia V

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses

抑制MNK1/2-eIF4E轴可损害黑色素瘤表型转换并增强抗肿瘤免疫反应。

Huang, Fan; Gonçalves, Christophe; Bartish, Margarita; Rémy-Sarrazin, Joelle; Issa, Mark E; Cordeiro, Brendan; Guo, Qianyu; Emond, Audrey; Attias, Mikhael; Yang, William; Plourde, Dany; Su, Jie; Gimeno, Marina Godoy; Zhan, Yao; Galán, Alba; Rzymski, Tomasz; Mazan, Milena; Masiejczyk, Magdalena; Faber, Jacek; Khoury, Elie; Benoit, Alexandre; Gagnon, Natascha; Dankort, David; Journe, Fabrice; Ghanem, Ghanem E; Krawczyk, Connie M; Saragovi, H Uri; Piccirillo, Ciriaco A; Sonenberg, Nahum; Topisirovic, Ivan; Rudd, Christopher E; Miller, Wilson H Jr; Del Rincón, Sonia V

Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma

撤稿:获得性BRAF抑制剂耐药性逆转突变型BRAF黑色素瘤的衰老样表型

Krayem, Mohammad; Najem, Ahmad; Journe, Fabrice; Morandini, Renato; Sales, François; Awada, Ahmad; Ghanem, Ghanem E

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies

靶向抑制素以抑制黑色素瘤生长并克服对靶向治疗的耐药性

Ahmad Najem, Mohammad Krayem, Serena Sabbah, Matilde Pesetti, Fabrice Journe, Ahmad Awada, Laurent Désaubry, Ghanem E Ghanem

Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 2019, 11, 1093

更正:Krayem 等人,《MAPK 抑制下 p53 重新激活对黑色素瘤放射治疗疗效的益处》,Cancers 2019, 11, 1093

Krayem, Mohammad; Sabbah, Malak; Najem, Ahmad; Wouters, An; Lardon, Filip; Simon, Stephane; Sales, François; Journe, Fabrice; Awada, Ahmad; Ghanem, Ghanem E; Van Gestel, Dirk

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma

PARP-1 和 c-Met 联合靶向治疗对野生型 BRAF 黑色素瘤放射治疗疗效的益处

Malak Sabbah, Ahmad Najem, Christophe Vanderkerkhove, Fabien Kert, Younes Jourani, Fabrice Journe, Ahmad Awada, Dirk Van Gestel, Ghanem E Ghanem, Mohammad Krayem

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE

使用丁硫氨酸亚砜亚胺扰乱氧化还原平衡放射增敏生长抑素受体-2 表达临床前模型对肽受体放射性核素治疗与 177Lu-DOTATATE

Wendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, Roland de Wind, Nicolas Sirtaine, Pieter Demetter, Marie Vercruyssen, Erwin Woff, Ioannis Karfis, Ghanem E Ghanem, Patrick Flamen, Zéna Wimana

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma

了解表型转换的分子机制及其与肿瘤微环境的相互作用,揭示黑色素瘤的新弱点

Najem, Ahmad; Soumoy, Laura; Sabbah, Malak; Krayem, Mohammad; Awada, Ahmad; Journe, Fabrice; Ghanem, Ghanem E

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance

瑞戈非尼诱导结直肠癌衰老和上皮-间质转化,促进耐药性

Pashalina Kehagias, Nadège Kindt, Mohammad Krayem, Ahmad Najem, Giulia Agostini, Elena Acedo Reina, Giacomo Bregni, Francesco Sclafani, Fabrice Journe, Ahmad Awada, Ghanem E Ghanem, Alain Hendlisz

Cytokine Landscape in Central Nervous System Metastases

中枢神经系统转移瘤中的细胞因子谱

Marin, Julie; Journe, Fabrice; Ghanem, Ghanem E; Awada, Ahmad; Kindt, Nadège